Bleakley Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Sell |
27,444
-13,535
| -33% | -$1.5M | 0.08% | 223 |
|
|
2025
Q1 | $4.59M | Buy |
40,979
+15,495
| +61% | +$1.74M | 0.15% | 134 |
|
|
2024
Q4 | $2.35M | Buy |
25,484
+2,414
| +10% | +$223K | 0.07% | 227 |
|
|
2024
Q3 | $1.93M | Buy |
23,070
+1,947
| +9% | +$163K | 0.06% | 260 |
|
|
2024
Q2 | $1.45M | Sell |
21,123
-768
| -4% | -$52.7K | 0.04% | 334 |
|
|
2024
Q1 | $1.6M | Buy |
21,891
+10
| +0% | +$733 | 0.05% | 330 |
|
|
2023
Q4 | $1.77M | Buy |
21,881
+1,869
| +9% | +$151K | 0.06% | 297 |
|
|
2023
Q3 | $1.5M | Sell |
20,012
-3,177
| -14% | -$238K | 0.05% | 310 |
|
|
2023
Q2 | $1.79M | Sell |
23,189
-1,451
| -6% | -$112K | 0.06% | 294 |
|
|
2023
Q1 | $2.04M | Sell |
24,640
-2,427
| -9% | -$201K | 0.07% | 250 |
|
|
2022
Q4 | $2.32M | Buy |
+27,067
| New | +$2.32M | 0.08% | 221 |
|